Shares of GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 35,585 shares trading hands.
GB Sciences Trading Up 11.1 %
GB Sciences Company Profile
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
Recommended Stories
- Five stocks we like better than GB Sciences
- Best Stocks Under $10.00
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Pros And Cons Of Monthly Dividend Stocks
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Ride Out The Recession With These Dividend Kings
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
